OHRP Market Cap History



Below is a table of the OHRP market cap history going back to 6/3/2013:

Date OHRP Market Cap
6/3/2013118.39M
6/13/2013148.66M
8/13/2013120.34M
12/27/2013158.56M
2/13/2014328.31M
5/12/2014161.07M
8/18/2014208.85M
12/22/2014220.77M
2/9/2015177.24M
5/11/201583.11M
8/6/201580.07M
12/14/2015124.66M
2/8/201694.39M
5/8/201694.18M
8/8/201682.83M
12/1/201681.79M
12/20/201662.93M
2/13/201748.55M
5/9/201735.41M
8/7/201734.85M
12/13/201785.42M
2/13/201818.07M
5/15/201811.29M
8/14/20189.03M
1/2/20196.21M
2/4/20195.73M
2/13/20196.34M
5/15/20197.41M

Also see: OHRP Shares Outstanding History
and OHRP YTD Return
OHRP Historical Market Cap:
-37.23% CAGR
OHRP Historical Market Cap: +-37.23% CAGR

Mouse over chart for data details
6/3/2013 ...5/15/2019
NeuBase Therapeutics is a pharmaceutical company. Co. has been focused on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. We show 28 historical shares outstanding datapoints in our OHRP shares outstanding history coverage, used to compute OHRP market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing OHRP market cap history over the course of time is important for investors interested in comparing OHRP's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of OHRP versus a peer is one thing; comparing OHRP market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like OHRP can fluctuate over the course of history. With this page we aim to empower investors researching OHRP by allowing them to research the OHRP market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree OHRP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Ohr Pharmaceutical (OHRP) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

OLMA Market Cap History
OM Market Cap History
OMED Market Cap History
OMER Market Cap History
OMGA Market Cap History
OMI Market Cap History
OMIC Market Cap History
ONCE Market Cap History
ONCR Market Cap History
ONCS Market Cap History
More Healthcare companies »

 

OHRP Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.